(Reuters) -Neutrogena-owner Kenvue's third-quarter sales fell short ... as strong sales of its self-care products helped offset weakness in other segments.

Bank of America Securities analyst Anna Lizzul maintained a Buy rating on Kenvue, Inc. (KVUE – Research Report) today. The ...

Kenvue announced financial results for the fiscal third quarter which ended September 29, 2024. Net sales in Q3 reached ...

The Neutrogena owner has named former Hydrafacial and Coty exec Stanleick as President, Skin Health & Beauty for North ...

The consumer products company has struggled with an underperforming skin health and beauty segment, while its self-care brands such as Tylenol and Benadryl have grown. AI-generated image Kenvue ...

We recently published a list of 8 Best Consumer Staples Stocks To Buy Right Now. In this article, we are going to take a look ...

Kenvue (KVUE) came out with quarterly earnings ... The results are expected to be released on November 19. This battery and personal care products company is expected to post quarterly earnings ...

Kenvue Inc., the owner of Tylenol and Neutrogena, reported sales that trailed estimates after its skin health and beauty category slowed. Organic sales rose 0.9% in the three months ended Sept.